Alambic Investment Management’s Corcept Therapeutics CORT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,323	Closed	-$267K	–	10
2020 Q3	$267K	Sell	15,323 -14,524	-49%	-$231K	2.93%	10
2020 Q2	$502K	Buy	29,847 +300	+1%	+$4.21K	1.26%	14
2020 Q1	$351K	Sell	29,547 -12,926	-30%	-$160K	0.85%	39
2019 Q4	$514K	Buy	+42,473	New	+$591K	0.43%	85
2019 Q2	–	Sell	-28,500	Closed	-$335K	–	314
2019 Q1	$335K	Buy	+28,500	New	+$354K	0.14%	215
2017 Q2	–	Sell	-18,800	Closed	-$206K	–	583
2017 Q1	$206K	Sell	18,800 -5,200	-22%	-$45.7K	0.03%	570
2016 Q4	$174K	Sell	24,000 -4,300	-15%	-$33.7K	0.03%	513
2016 Q3	$184K	Buy	28,300 +11,400	+67%	+$66.3K	0.04%	438
2016 Q2	$92K	Buy	+16,900	New	+$87.9K	0.02%	498